JUSTIN VANDERMEID: Open Payments
NPI 1548656374 · ABERDEEN, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$792 in 53 payments from 9 companies in 2025. Trend: 2023 $73 · 2024 $598 · 2025 $792
Food & beverage: $792
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $341 |
| Neurocrine BioSciences, Inc. | 6 | $111 |
| Alkermes, Inc. | 4 | $102 |
| Collegium Pharmaceutical, Inc. | 3 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
| Teva Pharmaceuticals USA, Inc. | 3 | $50 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: VRAYLAR, INGREZZA, Jornay PM, CAPLYTA, LYBALVI, ARISTADA, FANAPT, AUSTEDO XR.
Industry payments across SD — which companies pay providers there.
